GlassScriptPhysician profile
Nathan P King
NPI 1548934128
$2,862.13
in general payments reported to CMS, 2019-2025
17 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $266 · 2024: $1,421 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779 · Education: $83.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,778.63 |
| Education | $83.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $679.13 | 2024-2025 | |
| Alkermes, INC. | $396.32 | 2023-2025 | Lybalvi, Aristada, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $239.58 | 2024-2025 | Caplyta |
| Lundbeck LLC | $236.70 | 2023-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $189.78 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Neurocrine Biosciences, INC. | $185.08 | 2024-2025 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $182.14 | 2023-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $173.70 | 2023-2024 | Austedo Xr |
| Axsome Therapeutics, INC. | $158.81 | 2023-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $115.18 | 2024-2025 | Qelbree |
| Vanda Pharmaceuticals INC. | $100.07 | 2024-2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $49.56 | 2024-2025 | Invega Sustenna, Spravato |
| Ironshore Pharmaceuticals INC. | $42.92 | 2024 | |
| Collegium Pharmaceutical, INC. | $38.35 | 2025 | Jornay Pm |
| Sage Therapeutics, LLC | $29.49 | 2025 | Zurzuvae |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $27.73 | 2025 | Azstarys |
| Idorsia Pharmaceuticals US INC | $17.59 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.